homeopathy for addictions science
Read More“Scientists say homeopathy is impossible”→
/Science proves homeopathy
Read MoreAn integral approach to substance abuse.,Amodia DS, Cano C, Eliason MJ.
/integral approach to substance abuse and addictions
Read MoreAbout 70-80% of patients taking homeopathic treatment for chronic disease report improvement.
/About 70-80% of patients taking homeopathic treatment for chronic disease report improvement, and in at least one study they prefer it over conventional treatment, according to a collection of studies written up by our friends down under, Homeopathy Plus.
Possibly you are aware of the six-year Bristol Homeopathic Hospital study, which showed that out of 6,544 patients with chronic disease, sometimes of many years’ duration, 70.7 per cent reported positive health changes.
But there’s more.
A study on several alternative health modalities in Northern Ireland shows homeopathy narrowly edging out acupuncture with 79 per cent of patients reporting positive outcomes.
A study carried out at a health clinic in Dorset, England shows 84 per cent of patients reported improvement, and 81 per cent attribute their improvement to homeopathy.
A German study found that most parents with cancer-stricken kids who had them treated homeopathically rated their satisfaction rate as “very high” and would recommend homeopathy to other parents.
A large-scale Swiss study comparing patient satisfaction with homeopathic treatment to conventional medicine for chronic disease showed homeopathy scoring significantly better, with greater improvement and fewer side effects.
Finally, a 103-centre study in Switzerland and Germany followed 3,079 patients over eight years, and found:
* On average, disease severity decreased dramatically and improvements were sustained
* Three in ten patients stopped treatment because of major improvement
* Mental and physical quality of life scores increased substantially
* Biggest and fastest improvements happened for children and the patients who started out the most sick.
Conditions treated ran the gamut, covering both physical and emotional afflictions.
Those who wonder why homeopathy continues to grow in popularity worldwide despite a mechanism of action that defies common “wisdom” and a well-funded and highly-motivated opposition should take note of these studies.
Read the original article, which has more details and full citations, here.
Health Canada says it takes safety 'very seriously' in face of concerns about homeopathic remedy
/Ottawa has approved 8,500 homeopathic products, including remedy made from rabid dog saliva
Bethany Lindsay · CBC News · Posted: Apr 18, 2018 4:00 AM PT | Last Updated: April 18
http://snip.ly/fmamj
More than 8,500 homeopathic treatments are approved by Health Canada. (Josh Reynolds/Associated Press)
The long list of so-called homeopathic nosodes approved by Health Canada include remedies made from the bacteria that causes chlamydia, the cerebral fluid of meningitis patients and cancer cells — to name just a few.
After B.C.'s senior physician questioned the federal approval of one of these remedies, a substance developed from the saliva of a rabid dog, Health Canada will only say that it takes the safety of health products "very seriously."
A Health Canada spokesperson said no one was available Tuesday for an interview about the remedy used by a Victoria naturopath to treat a small boy's behaviour problems, but offered a written statement instead.
"Homeopathic products ... are regulated as natural health products (NHPs) under the Natural Health Products Regulations," the statement reads.
"Health Canada takes the safety of health products on the Canadian market very seriously. Should a product not meet the requirements set out in the associated product monograph and guidance, Health Canada will take action."
The homeopathic remedy, which is marketed as lyssinum, lyssin or hydrophobinum, is one of more than 8,500 homeopathic products regulated by the federal government.
http://www.cbc.ca/news/canada/british-columbia/health-canada-says-it-takes-safety-very-seriously-in-face-of-concerns-about-homeopathic-remedy-1.4623775
H.I.P. Services
/Access Natural Healing, an Eastside walk-in homeopathic clinic, is offering a homeopathic immunization program for children and travellers—the only program of its kind in the province. And if needles give you the heebie jeebies, take heart: these non-toxic vaccinations are administered orally. 101-1416 Commercial Dr., accessnaturalhealing.com
Read MoreHepatitis B vaccine induces apoptotic death in Hepa1-6 cells.
/http://www.greenmedinfo.com/article/hepatitis-b-vaccine-induces-cell-death-liver-cells-and-mouse-liver
Abstract Title:
Hepatitis B vaccine induces apoptotic death in Hepa1-6 cells.
Abstract Source:
Apoptosis. 2012 Jan 17. Epub 2012 Jan 17. PMID: 22249285
Abstract Author(s):
Heyam Hamza, Jianhua Cao, Xinyun Li, Changchun Li, Mengjin Zhu, Shuhong Zhao
Article Affiliation:
Key Lab of Agricultural Animal Genetics, Breeding, and Reproduction of Ministry of Education, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China, Heyam68_hamza@yahoo.com. Abstract:
Vaccines can have adverse side-effects, and these are predominantly associated with the inclusion of chemical additives such as aluminum hydroxide adjuvant. The objective of this study was to establish an in vitro model system amenable to mechanistic investigations of cytotoxicity induced by hepatitis B vaccine, and to investigate the mechanisms of vaccine-induced cell death. The mouse liver hepatoma cell line Hepa1-6 was treated with two doses of adjuvanted (aluminium hydroxide) hepatitis B vaccine (0.5 and 1 μg protein per ml) and cell integrity was measured after 24, 48 and 72 h. Hepatitis B vaccine exposure increased cell apoptosis as detected by flow cytometry and TUNEL assay. Vaccine exposure was accompanied by significant increases in the levels of activated caspase 3, a key effector caspase inthe apoptosis cascade. Early transcriptional events were detected by qRT-PCR. We report that hepatitis B vaccine exposure resulted in significant upregulation of the key genes encoding caspase 7, caspase 9, Inhibitor caspase-activated DNase (ICAD), Rho-associated coiled-coil containing protein kinase 1 (ROCK-1), and Apoptotic protease activating factor 1 (Apaf-1). Upregulation of cleaved caspase 3,7 were detected by western blot in addition to Apaf-1 and caspase 9 expressions argues that cell death takes place via the intrinsic apoptotic pathway in which release of cytochrome c from the mitochondria triggers the assembly of a caspase activation complex. We conclude that exposure of Hepa1-6 cells to a low dose of adjuvanted hepatitis B vaccine leads to loss of mitochondrial integrity, apoptosis induction, and cell death, apoptosis effect was observed also in C2C12 mouse myoblast cell line after treated with low dose of vaccine (0.3, 0.1, 0.05 μg/ml). In addition In vivo apoptotic effect of hepatitis B vaccine was observed in mouse liver.
Pubmed Data : Apoptosis. 2012 Jan 17. Epub 2012 Jan 17. PMID: 22249285 Article Published Date : Jan 17, 2012 Study Type : Animal Study
Autism Is A Research Growth Area: No Profit in Finding the Cause
/Autism Is A Research Growth Area: No Profit in Finding the CauseFebruary 19, 2012 by admin in Autism, Featured, Science
http://gaia-health.com/gaia-blog/2012-02-19/autism-is-a-research-growth-area-no-profit-in-finding-the-cause/
The Mind of the Autism Researcher
Attempts to prove that autism is genetic, physical, or chemical in nature continue unabated. It’s proven to be a most lucrative specialty for researchers. However, the studies that promote the genetics-not-vaccine concept tend to show only the effects of autism. They demonstrate nothing to indicate the actual cause, though they often imply, or even outright state, otherwise.
That alone should tell us what’s become of most autism research: it’s a growth area. Autism research has become very much the same as Big Pharma-based medicine. In fact, much of it is funded by pharmaceutical corporations.
To find a disease cause and solution to prevent disease isn’t profitable. However, to find even the most minuscule physical, genetic, or chemical change in someone with an existing disease means that even more money can be squeezed out of the research funders like the National Institutes of Health (NIH) and the National Institute of Mental Health (NIMH), agencies funded by taxpayers. Anything that leads away from causes and focuses on the physiochemical effects of autism always leads to more questions and more research funds.
Gaia Health recently documented an autism study demonstrating that it shows the opposite of what is claimed. The authors attempt to demonstrate that physical changes in the brains of autistics shows that vaccines could not be the cause. In reality, the study shows a close parallel between those changes and autism’s development. That fact, though, could not be mentioned. It would likely have resulted in the researchers’ funding sources drying up. Study: White Matter Changes in Autism
A recent study published in the American Journal of Psychiatry(1) says that children defined as high risk for developing autism become autistic because of changes in the brain’s white matter, and that autism can be predicted in advance based on MRIs showing such changes. This is all fine and dandy—but it says precisely nothing about what causes these changes.
This study has a continuing medical education couse associated with it on MedPage Today. Passing the related test of two simple questions provides the reader, who is presumed to be a doctor, with .25 CME units. The doctor can easily collect these training credits within a few minutes, never leaving the comfort of home or office, or more significantly, without even having to bother reading the study itself. No thought process is required to determine whether the study holds any validity. The single-page course simply summarizes and regurgitates the study’s claims with no attempt to analyze whether it’s meaningful.
The result of this is sure to be yet more MRI tests on infants, which will, of course, further increase the cost of medicine and will likely produce no benefit to children—unless yet another toxic drug is considered helpful. Study: Genetic Changes in Autism
Another study, published in PLoS Genetics(2), states that functional mutations in the SHANK2 gene, resulting in changes in synapses, are associated with some, but not all, autism. A functional mutation is not a birth defect. It is caused by something.
However, the study researchers weren’t interested in what causes the SHANK2 gene to be damaged. They were quite satisfied with the idea that the damage was just spontaneous. One would have thought that the researchers would at least be curious about what causes these changes—but apparently curiosity that doesn’t bring in big financial payments has been bred out of researchers.
Their interest was only in the idea where the finding indicates that several genes acting in combination must be associated with autism. Author Bergeron states:
There are so many combinations that might be important. We still have a lot of work to do at the genetic level.
Wow! Those researchers may have found a mother lode of research grants for all the follow-up research that they can now claim should be done. Just imagine the money that’s going to be made by Big Pharma in vaccines or drugs to treat the broken SHANK2 genes. Obviously, finding the cause of those broken genes would interfere with the profits to be made in attempts to fix them. Study: Brain Activity Changes in Face Recognition
A study published in Nature Neuroscience(3) claims that functional MRIs can examine the fusiform gyrus, a part of the brain believed to focus on face identification, and that it will be able to study people—specifically, autistics—who are too unresponsive to cooperate in such studies. Author J.D. Gabrieli told the Simons Foundation:
Functional brain studies have been limited to the most high-functioning individuals, because we had to use active tasks that required following instructions. This method may open ways to look at the many autism patients who cannot follow task instructions.
Thus, this study has been performed to pave the way for yet more studies of autistic people. Whether it might actually benefit them is … well, that doesn’t seem to be the issue. The Third Rail of Medical Research
There exists just one thing that autism researchers won’t touch: the cause. It’s the third rail of medical research. Autism has developed into a huge money-maker for modern medicine and its supporting agencies. Big Pharma is now selling drugs to send autistic kids to oblivion and further damage their brains. Doctors have a huge group of children whose parents are conditioned to take them back over and over again for tests and treatments, none of which help. Agencies and charities have organized to promote awareness of the condition and, in most cases, to promote the well-being of the top-line managers’ pay. Researchers and medical journals all help feed into this newly profitable condition. None of them actually help. For that, you must leave the modern medical system and find alternatives.
If the cause of autism were officially found. The focus would be on prevention. But then, none of this enormous pool of money could be tapped by any of these groups. Their bottom line is benefited by putting on blinders to the most likely cause, vaccines. To that end, they’ve established a PR campaign to convince the public—not to mention their own members—that vaccines aren’t the cause of autism and that autism isn’t truly a new disorder, but one that was previously unrecognized. Of course, as most parents of autistic children can state without reservation, there is no possibility that what’s happened to their children could ever have gone unnoticed.
So, they’ve developed a most magnificent arrangement of patting each others’ backs:
The doctors get to take absurdly simple CME courses that tell of phony breakthroughs, thus getting that nuisance requirement of continuing education out of the way without stress. Medical websites that take most of their money from Big Pharma can pump out these nonsensical courses, pulling doctors to their sites for the easy ride. Doctors get more and more patients. Medical suppliers get to sell more and more equipment for tests. Big Pharma gets to develop new drugs and find ways to push old ones on autism sufferers. To support it all and give the seal of so-called “evidence based medicine” to these practices, medical researchers produce study after study, all of them focused on anything but finding the cause of autism.
It’s a cozy arrangement for everyone but the autistic children, their families, and society as a whole. Finding the cause would shut down the researchers’ gushing funding tap, and preventing autism would cut into all arenas of this exploding area of the medical industry.
Sources:
(1)Differences in White Matter Fiber Tract Development Present from 6 to 24 Months in Infants with Autism, doi:10.1176/appi.ajp.2011.11091447. (2)Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders (3)Anatomical connectivity patterns predict face selectivity in the fusiform gyrus, doi: 10.1038/nn.3001
--
Elena Cecchetto DCH, CCH, RSHom(NA)
604-568-4663
Facebook:
http://www.facebook.com/homeopath#!/AccessNaturalHealing
Twitter:
http://twitter.com/#!/accesshealing
LinkedIn:
http://www.linkedin.com/profile/edit?trk=hb_tab_pro_top
“The information contained in this message is for educational purposes and constitutes a response to a private request for information only and does not constitute a solicitation for services and makes no claim or promise that any product or service that may cure any condition or ailment,”
[Fwd: [HOMEOPATHY] Who is more neutral than the Swiss...]
/
|
||||||||||||
--
Your Wellness Team at
~Access Natural Healing Centre~
604-568-4663
Facebook:
http://www.facebook.com/homeopath#!/AccessNaturalHealing
Twitter:
http://twitter.com/#!/accesshealing
LinkedIn:
http://www.linkedin.com/profile/edit?trk=hb_tab_pro_top
“The information contained in this message is for educational purposes and constitutes a response to a private request for information only and does not constitute a solicitation for services and makes no claim or promise that any product or service that may cure any condition or ailment,”
How Safe Is Universal Hepatitis B Vaccination? by Burton A. Waisbren, Sr., M.D., F.A.C.P.
/How Safe Is Universal Hepatitis B Vaccination? by Burton A. Waisbren, Sr., M.D., F.A.C.P.
http://www.waisbrenclinic.com
INTRODUCTION Universal hepatitis B vaccination of infants in the United States, regardless of risk factors, was first proposed by Margolis and his coworkers of the hepatitis branch of the Center for Disease Control and Prevention in Atlanta, Georgia.(1,2) The concept was endorsed and augmented by West and his coworkers at the Merck Sharpe and Dohme research laboratories in West Point, Pennsylvania.(3) The rationale presented for universal vaccination of infants in the U.S. stemmed from the failure of the current strategies for controlling this disease and not from trials that demonstrated the effectiveness or safety of a universal hepatitis B vaccination program.(4,5) In spite of this, universal hepatitis B vaccination is achieving wide spread acceptance among medical organizations and is being vigorously pursued in many sections of the country.(5,6)
To be presented here are four patterns that raise some concerns about vaccinating all babies in the U.S. with the hepatitis B vaccine. The patterns are as follows: The historical pattern of events that followed the introduction of an antirabies vaccine in the late 1800's and of warnings regarding probable occurrence of vaccine complications given by medical scientists during the past 50 years; the pattern revealed by animal experimentation that showed that viruses and viral particles may cause demyelination and autoimmunity in a variety of species; the pattern of autoimmunity and demyelination that has been caused by the hepatitis B infection, itself; the pattern of clinical reports that reveal that demyelination and autoimmunity have appeared in patients vaccinated with hepatitis B vaccines.
Reasonable steps that might be taken to address the concerns evoked by the above patterns will be discussed.
--------------------------------------------------------
Postvaccinal Encephalomyelitis and Warnings by Medical Scientists
Postvaccinal encephalomyelitis has been recognized and accepted as a clinical entity since it first occurred after Pasteur's antirabies vaccine was used. (7) At first the encephalomyelitis was thought to be caused by the nervous tissue in which the virus used for the vaccine was grown. (7) However, postvaccinal encephalomyelitis has appeared in patients who received vaccine grown in duck eggs, so it is now thought that the syndrome is caused by something present in the dead virus.(8) Postvaccinal encephalomyelitis has since been observed after a wide variety of vaccinations.
Within the past 30 years representatives of the medical establishment have discussed and warned about neurologic complications of various vaccines. (9-12) Wilson, in his 1967 monograph regarding vaccine complications, pointed out that there are no insurance policies without premiums and that strict attention must be paid to the premiums exacted by each vaccine.(9) Miller, in 1954, discussed the neurologic sequelae of vaccination and the difficulty of these complications being recognized and accepted. (10) Zuckerman, in an article in 1974 in Nature entitled "Hepatitis Vaccine: A note of caution" pointed out that autoimmunity might well follow the hepatitis B vaccinations because the disease, itself, involved autoimmunity.(11) He suggested, "careful assessment of all vaccine effects on the immune system."(11) As late as 1988, Hilleman, who some call the "father" of hepatitis B vaccine, warned "the message from the hypothetical hepatitis B example is that the administration of antigens or monoclonal antibodies that directly or indirectly raise antibodies that attach to host cell receptors may carry large liabilities even though they might provide a convenient means for preventing viral access to host cells... antibodies attached to cell receptors may invite the same kinds of adverse response that are believed to be responsible for a variety of autoimmune disorders." (12)
Experiments In Animals That Lead To Concerns about the Hepatitis B Vaccine
Experiments done on animals in the past 60 years have yielded data that add to the concerns about present day viral vaccines. These experiments have shown that polypeptide chains of the types found in viruses that are homologous or nearly homologous with myelin can cause demyelination and have shown that viruses, themselves, can cause demyelination.(13)
The experiments started in 1956 when Rivers showed that myelin injected into monkeys caused demyelination.(14) Wakesman expanded these studies and developed an experimental model in which myelin and adjuvant consistently caused demyelinating disease in mice and rabbits.(15) This has been widely accepted as a model for demyelinating diseases in humans and is called experimental allergic encephalomyelitis (EAE). (16) Stohlman found that a DNA virus called JHM could cause demyelination in mice. (17) Oldstone then presented experimental evidence that autoimmunity in humans was caused by polypeptides in viruses that were homologous to those in human tissue. (18) Fujinami and Oldstone produced EAE in rabbits with proteins from hepatitis B virus that had polypeptides in it that were homologous with myelin.(19) Ziegler produced EAE in rabbits with the Swine Flu Vaccine and adjuvants.(20)
Westall and Root-Bernstein presented data that suggested a syndrome they called Multiple-Antigen-Mediated-Autoimmunity (MAMA) could occur in animals and humans. (21) They postulated that the MAMA Syndrome was operative in postvaccinal encephalomyelitis as well as in EAE.(21) Root-Bernstein hypothesized that this syndrome could occur in humans if four conditions were met. The first was demonstrated homology between an antigen and host tissue. The second was the presence simultaneously, of more than one antigen. The third was complementarity between the antigens shown to be present. The fourth was the additional presence of a bacterial adjuvant. As will be discussed later, all of these requirements can be tested for as a possible explanation for post hepatitis B vaccine reactions.
Finally, the HLA patterns of experimental animals has been shown to influence their susceptibility to experimental demyelinating diseases.(22)
Hepatitis B Infection Causes Autoimmunity and Demyelination
Another group of patterns regarding the consideration of universal hepatitis vaccination, without factoring in risk factors that have been largely ignored, are those revealed by the findings that the infection, itself, causes autoimmunity and demyelination. In 1977, London first reported that autoimmune disease was caused by circulating immune complexes caused by viral antibody association.(23) In 1987, Tsukada reported demyelinizing neuropathy associated with the hepatitis B infection.(24) Discussions and case reports regarding autoimmunity occurring with the hepatitis B infection have been presented by Vento et al and McFarlane et al.(25,26) As early as 1976, Zuckerman cautioned that since autoimmunity is involved in the pathogenesis of hepatitis B infections that it might be augmented by a hepatitis B vaccination.(11)
Reports Of Demyelination and Autoimmunity After Hepatitis B Vaccination
Clinical experiences since the general release of hepatitis B vaccines suggest that clinical counterparts of the animal studies and autoimmunity that occurs after the hepatitis B infection occur after hepatitis B vaccination. The first report of demyelination after the hepatitis B vaccination was that of Ribera and Dutka in 1983. The complication was transient.(27) The authors stated inflammatory polyradiculoneuropathies after both viral diseases and vaccinations have been widely reported.(27) They emphasized the necessity of continued surveillance of the use of hepatitis B vaccine.(27) I have noted seven cases of a neurologic picture resembling multiple sclerosis (MS) after hepatitis B vaccination. (28) In 1987, Fried et al reported uveitis that occurred in a 20-year-old nurse after a booster dose of hepatitis B vaccine.(29) They pointed out that there is a higher than normal level of hepatitis B antibodies in some uveitis patients. They postulated that these antibodies combined with surface antigens in the vaccine could form a disease producing immune complex.(29)
Shaw et al reported a post marketing surveillance study regarding neurologic events after the hepatitis B vaccine in 1988. (30) An estimated 850,000 individuals had received the vaccine by the time of their study. They found ten cases of Bell's palsy, nine cases of Guillain-Barre Syndrome, five cases of lumbar radiculopathy, three cases of brachial plexus neuropathy, five cases of optic neuritis, and four cases of transverse myelitis. They concluded, on the basis of the controversial epidemiologic methods used to study the Swine Flu epidemic of 1976, that the risk of the vaccine was outweighed by the prophylactic benefits in "high risk groups."(30,31) However, even using these methods, they concluded that the demyelinating disease, Guillain-Barre Syndrome, occurred more often in individuals who had been vaccinated than in the general population.(30) In 1988, Biron et al reported a case of myasthenia gravis that occurred after anesthesia and a hepatitis B vaccination.(32) They postulated that the autoimmune disease was due to the "challenge" to the immune system by the vaccine.(32) In 1989, Goolsby reported a case of erythema nodosum that occurred after recombinant hepatitis B vaccine. (33) In 1991, Herroelen et al reported on two patients who developed symptoms of increasing demyelination after a vaccination of recombinant hepatitis B vaccine. (34) He mentioned that their HLA patterns might be a contributing factor. Seven hundred reports of adverse reactions to the hepatitis B vaccine were sent in to the Vaccine Adverse Events Reporting Systems (VAERS) between October 1990 and September 1991.(35) This system was set up via the National Childhood Vaccine Injury Act of 1986. Sixteen percent of these reports were of damage presumed to be to the myelin of the nervous system. There were 21 cases of facial paralysis and six cases of MS. Eighty-two of the complications occurred in patients who received plasma derived vaccine and 18 occurred in those who received recombinant vaccine. (35) This difference can be explained by the fact that at the time the VAERS were examined, the recombinant vaccine had just come into general use. In 1990, in the World Health Organization Drug Information Bulletin two cases of optic neuritis and one case of Guillain-Barre Syndrome were reported to be among the 200 reports of adverse reactions that were reported by the Australian National Regulatory Body. (36) One patient had vertigo and diplopia attributed to demyelination eight months after the vaccination.(36)
In 1993, Trevisani et al reported a case of transverse myelitis that followed a recombinant vaccination in an 11 year-old girl.(37) Their arguments for a causal link between the vaccination and the transverse myelitis were the temporal association (21 days), the previous report of Shaw's in which the same complication occurred, and no clinical evidence of any other cause of the disease.(37) They pointed out that transverse myelitis was occasionally found in patients with hepatitis B. (37) This suggested to them that there might be antigenic determinants held in common with the capsular antigen of the hepatitis B vaccine and myelin.(37)
In 1993, Nadler et al reported a case of "classic MS," the prodromal of which appeared 10 days after a recombinant vaccination. (38) They stated that the benefits of the hepatitis B vaccination, among the population for "which it is usually recommended," far out weigh any potential risks.(38) In 1990, there was a report in the British Medical Journal of vasculitis related to the hepatitis B vaccination.(39) It was felt to be due to immune complex disease. In 1993, Brezin et al reported visual loss and eosinophilia after a recombinant hepatitis B vaccine.(40)
In 1995, Kaplanski et al reported a case of central nervous system demyelination that occurred in a 37-year-old man two weeks after receiving the third hepatitis B injection.(41) This patient had the same haplotype as the patient reported by Herroelen.(34) They suggested that the hepatitis B vaccination could potentially induce CNS demyelination in patients with HLA, B7, DR2 haplotype, whether or not these patients have a history of MS.(41)
Vautier and Carty in 1994 reported a case of classic rheumatoid arthritis that followed a hepatitis B vaccination.(42) They brought up the fact that the patient was HLA, DR4 positive which would be consistent with both animal and previous clinical reports regarding complications of the hepatitis B vaccine.(22,33,42) Hassan and Oldham reported two cases of reactive arthritis and Reiter's Syndrome that occurred after a recombinant hepatitis B vaccine.(43) They cite a personal communication from the manufacturer that stated that in 11 cases reported to them of reactive arthritis following recombinant hepatitis B vaccine that six had a recurrence of symptoms after a second vaccination.(43)
In 1995, Tartaglina et al reported a case of postvaccinal myelitis that occurred one month after a hepatitis B vaccination.. (44) They suggested that complications of this sort may be under reported because there can be a delay in symptom occurrences.(44) In the case they reported, symptoms did not occur until one month after a single injection of the vaccine. No other cause of the myelitis was shown by a MRI.(44)
DISCUSSION
How might the concerns evoked by the material that has been presented be addressed?
Parents of babies and adolescents who have little chance of being exposed to hepatitis B should be made aware of the potential dangers of the vaccine. A perspective, inclusive, long term follow up study of a large number of individuals who have received the vaccine should be done and the results should be made available to the parents of children who are to be vaccinated. While these admittedly tedious studies are being conducted, databases available through societies such as the Multiple Sclerosis Society might be used to determine if an inordinate number of patients with multiple sclerosis had received a hepatitis B vaccination prior to being diagnosed.
The literally hundreds of individuals who have been reported to VAERS and pharmaceutical companies, who claim to have suffered demyelination and autoimmunity from a hepatitis B vaccine, should be followed up to determine their HLA patterns to ascertain if host factors are partially causative of the complication.(22,33)
A large group of individuals who are to be vaccinated should have before and after determinations by the methods of Zhang, Wucherpfennig and Strominger of the percentage of their T-cells that exhibit antimyelin activity to determine if vaccination does evoke such cells in some individuals with certain HLA patterns.(47,48)
The ability of vaccines when injected with adjuvant into animals to cause EAE should be tested using the methods of Fujinami and Ziegler.(19,20)
The hypothesis and studies of Westall and Root-Bernstein that indicate a multifactorial pathogenesis of postvaccinal encephalomyelitis suggest a series of studies that could be done on vaccines and on patients who developed complications after the hepatitis B vaccination.(21) Hepatitis B vaccine and all other vaccines should be tested for the extent of their polypeptide homology with human tissue.(13,21) If significant homology were to be demonstrated, the offending polypeptides could be removed from the vaccine or synthetic vaccines could be produced without them. (49,50) If such a homology were to be demonstrated, it would fulfill the first requirement for the provocative hypothetical MAMA Syndrome of Westall and Root-Bernstein. (21) The second requirement for the MAMA Syndrome is that multiple antigens are present.(21) These could be tested for by serologic studies for the Epstein-Barr Virus and other viruses that already have been indicted in this syndrome.(21) The third requirement that complementarity between antigens must be demonstrated could be tested for by complementarity studies between the hepatitis B vaccine and other antigens uncovered by the aforementioned serologic tests. (51) The fourth requirement that an adjuvant be present could be tested for by serologically determining whether muramyl peptides are present. (52) These peptides are well established adjuvants and are ubiquitous as part of the cell walls of all bacteria.(52)
The above-mentioned studies might well yield information that would not only make all vaccines safer, but could lead to means to prevent postvaccinal autoimmunity by the methods shown to work in animals by Westall and Root-Bernstein and Norga et al.(53,54)
Finally, it should be emphasized that the concerns voiced above in no way denigrate worldwide programs that are attempting to reduce hepatitis B in populations of extremely high risk, both internationally and in the U.S.(55) Certainly, there should be no abrupt stopping of present vaccination programs in the U.S., but it does seem reasonable to develop an informed consent that discloses to parents the potential dangers of the vaccine. Parents then would be able to intelligently decide whether the risk involved justifies their child receiving the vaccination. This might be particularly reasonable in areas of the U.S. in which the incidence of hepatitis B is very low.
ABC News Doc Recommends Homeopathy for Stomach Viruses
/ABC News Doc Recommends Homeopathy for Stomach Viruses
January 26, 2012 by Peter
Filed under Blog, Flu, Homeopathy In The News, Parents Guide to Children's Health
ABC News doc - Dr. Albert Levy M.D. just did a story for ABC on stomach viruses. Eli Manning of the New York Giants recently had a bad stomach virus - so ABC wanted to share treatment options with their viewers. In the piece, viewable at the link below, Dr. Albert Levy M.D. recommends homeopathic remedies for these viruses. Good piece. Check it out!
And if you want to learn how to treat stomach bugs and other acute conditions like earaches, sore throats, coughs, flu and more - consider becoming a member of the National Center for Homeopathy.
(http://www.nationalcenterforhomeopathy.org/member-benefits/)
--
Your Wellness Team at
~Access Natural Healing Centre~
604-568-4663
Facebook:
http://www.facebook.com/homeopath#!/AccessNaturalHealing
Twitter:
http://twitter.com/#!/accesshealing
LinkedIn:
http://www.linkedin.com/profile/edit?trk=hb_tab_pro_top
“The information contained in this message is for educational purposes and constitutes a response to a private request for information only and does not constitute a solicitation for services and makes no claim or promise that any product or service that may cure any condition or ailment,”
Testimonial for "H.I.P" aka Homeopathic Immunization Program
/Testimonial for "H.I.P" aka Homeopathic Immunization Program http://youtu.be/pKmUGBbGF0M
Homeopathy as an alternative to antibiotics in diarrhoea in piglets
/Homeopathy as an alternative to antibiotics in diarrhoea in pigletsA research study conducted at the Wageningen University in the Netherlands suggests that homeopathy may be an alternative to antibiotics in neonatal diarrhea of piglets.The overuse of antibiotics in poultry, beef cattle and swine production poses a serious threat to human health, animal health and the environment. Sustainable alternatives to antibiotics are desperately needed.
In the organic livestock sector antibiotics are preferably replaced by complementary or alternative medicines (CAM), of which homeopathy is the most frequently applied. Homeopathic treatment has significant benefits since there are no residues of homeopathic medicines in animal products, nor does homeopathy generate resistant microorganisms.
The Biological Farming Systems Group at the Wageningen University in the Netherlands recently conducted a research study to investigate if homeopathy might be an alternative to antibiotics in one of the most common illnesses in swine which is neonatal diarrhoea of piglets. This disease leads to weight loss and increased piglet mortality, which has substantial economic consequences. Conventional treatments of Escherichia coli (E. coli) diarrhoea is administration of antibiotics to affected piglets, or preventive vaccination of the sows.
To investigate if E. coli diarrhoea in neonatal piglets could be prevented by homeopathy, the researchers set up a randomised, observer blind and placebo-controlled trial. On a commercial pig farm 52 sows of different parities, in their last month of gestation, were treated twice a week with either the homeopathic agent Coli 30K or placebo. The 525 piglets born from these sows were scored for occurrence and duration of diarrhoea.
Piglets of the homeopathic treated group had significantly less E. coli diarrhoea than piglets in the placebo group (P < .0001). Especially piglets from first parity sows gave a good response to treatment with Coli 30K. The diarrhoea seemed to be less severe in the homeopathically treated litters, there was less transmission and duration appeared shorter.
Advantages at farm level are application of the treatment by the farmer and cost reduction. These advantages and the positive results from this study make the homeopathic agent Coli 30K an attractive potential alternative in the prevention of E. coli diarrhoea. This study also suggests that homeopathic treatment in livestock may help the European citizen be protected from pharmacological residues in animal products and thus reduce the problem of antibiotic resistance.
Reference Camerlink I, Ellinger L, Bakker EJ, Lantinga EA (2010). Homeopathy as replacement to antibiotics in the case of Escherichia coli diarrhoea in neonatal piglets. Homeopathy, 99; 57–62.
PubMed abstract can be found here, full article here: http://www.homeopathyeurope.org/media/news/homeopathy-as-an-alternative-to-antibiotics-in-diarrhoea-in-piglets
--
Your Wellness Team at
~Access Natural Healing Centre~
604-568-4663
Facebook:
http://www.facebook.com/homeopath#!/AccessNaturalHealing
Twitter:
http://twitter.com/#!/accesshealing
LinkedIn:
http://www.linkedin.com/profile/edit?trk=hb_tab_pro_top
“The information contained in this message is for educational purposes and constitutes a response to a private request for information only and does not constitute a solicitation for services and makes no claim or promise that any product or service that may cure any condition or ailment,”
Homeopathy Halts Cuban Epidemic Better Than Vaccines
/Homeopathy Halts Cuban Epidemic Better Than Vaccines
Swamp fever, also known as leptospirosis, is a major problem in Cuba. Each year, an epidemic of swamp fever plagues the island nation during the flood season when the illness is transferred from rats to people.
The very serious symptoms of swamp fever include fever, diarrhea, vomiting, jaundice, meningitis, liver failure, renal damage, respiratory illness and in many cases, death.
Fortunately for Cuba, Big Pharma is not much interested in monopoly control of its healthcare system which leaves the door open for alternative and nontoxic approaches to health to bloom.
In this environment very open to homeopathy, the Finlay Institute, a Cuban research foundation, worked with Cuban doctors to develop a homeopathic nosode for swamp fever.
The remedy was based on the homeopathic principle that “like cures like” and was developed and administered on a wide scale as a preventative treatment. In 2008, 2.5 million people who were most susceptible to the disease were treated with 2 doses of the remedy seven to nine days apart. The Cuban Ministry of Public Health implemented and managed the operation.
The results of this effort were nothing short of spectacular. The typical rate of infection when vaccination and antibiotics are used is a few thousand cases per year including some deaths.
When the homeopathic remedy was used, however, only ten cases of swamp fever were reported among the 2.5 million treated with the homeopathic nosode with no mortality of any hospitalized patients!
The financial cost to the Cuban government for this astonishingly successful health campaign was only $200,000 compared with the $2,000,000 that would have been incurred for conventional vaccination and antibiotics.
Not only was homeopathy clearly more effective than vaccines for preventing swamp fever, it was also a much more cost effective solution with no toxic side effects such as is the case with vaccination.
Homeopathy for epidemics works. There is no need for toxic and expensive vaccine injections which produce masses of auto-immune compromised children and adults alike in need and dependent upon – more drugs!
The catalyst for widespread use of homeopathic nosodes as a safe and effective alternative to the ever growing list of toxic vaccines must come from parents, in particular mothers. Mothers must refuse toxic vaccines for their children and demand this type of safe and effective remedy at a grassroots level as it will never come from the conventional medical establishment which has a strongly invested profit motive for keeping things the way they are.
Sarah, The Healthy Home Economist
http://www.thehealthyhomeeconomist.com/homeopathy-halts-cuban-epidemic-better-than-vaccines/
--
Your Wellness Team at
~Access Natural Healing Centre~
604-568-4663
Facebook:
http://www.facebook.com/homeopath#!/AccessNaturalHealing
Twitter:
http://twitter.com/#!/accesshealing
LinkedIn:
http://www.linkedin.com/profile/edit?trk=hb_tab_pro_top
“The information contained in this message is for educational purposes and constitutes a response to a private request for information only and does not constitute a solicitation for services and makes no claim or promise that any product or service that may cure any condition or ailment,”
Effective Cancer Treatment with Popular Cuban Homeopathic Drug Vidatox
/Effective Cancer Treatment with Popular Cuban Homeopathic Drug Vidatox
What is Vidatox?
Vidatox is a drug produced from five protein peptides extracted from the venom of the blue scorpion (Rophalorus junceus), which is endemic to Cuba and which has analgesic, anti-inflammatory and anti-carcinogenic effect in more than 15 different cancer cell lines. The result of 15 years of research, by October 2010 Vidatox had been tested on more than 10,000 cancer patients, some 3,500 of them foreigners, with positive results both in improving quality of life and stopping tumour growth.
Labiofam, a Cuban pharmaceutical laboratory, is set to release a new homeopathic cancer drug to the international market. Marketed as Vidatox, it is the result of work by Cuban biologist, Misael Bordier with the venom of the blue scorpion.
The medication was produced from over 5,000 scorpions of the Rhopalurus junceus variety, native to eastern Cuba. According to the company, it has no contraindications and is compatible with any other oncological treatment.
The company presented the results of its Vidatox research in its first international congress in late September in Havana before some 500 delegates from all parts of the world. Vidatox International Congress: Results of Scientific Research
The Company is all set to register its homeopathic version in coming days and go for its commercial production. The medication, and Labiofam says that its homeopathic version should be registered in the coming days and could be commercially produced immediately. González added that the company would continue research to produce synthetic or biotechnological versions of the compound.
Report on the Current Situation Regarding Vidatox 30 CH (Translated from Spanish)
The use of natural products in traditional and alternative medicine is widely practiced today. In particular, the Poison Scorpion have been little studied and a few years ago began their potential pharmacological evidence.
In Cuba there are 32 species and subspecies of scorpions, including 28 endemic among the most common being the scorpion Rhopalurus junceus the which has been used in traditional medicine to apply under the Cuban stomach in case of urinary retention and improvement of some diseases.
The 30 CH VIDATOX ® is the registered trademark for the drug homeopathic and natural (health record: H-11 – 038 – NO2) obtained from junceus Rhopalurus scorpion venom, endemic to Cuba, indicated as adjunctive therapy in the treatment of symptoms caused by effects of cancer and pain relief. The decision to produce is the result over 15 years of a research project aimed at characterization of the poison, and evaluating their potential as antitumor agent, analgesic, antiinflammatory, and toxicological safety.
Based on the evidence of safety and efficacy provided by the preclinical research, VIDATOX 30 CH was applied in a controlled study of 174 cancer patients of both sexes with histopathological diagnosis confirmed, which was administered 5 sublingual drops every 12 hours during the period 3/12/2007 to 2/2/2010.
Samples were grouped by location, neoplastic families, stage evolution of the disease, treatment received and the presence of cancer neoplasia. At the conclusion of the study period (2 years) lung, prostate, colon, breast and uterus were the most sensitive effect of the product. Similarly, it is demonstrated that administration of medication in 96% of patients, led to a life of greater than 12 months regardless of the location and stage of disease, especially in those patients for whom there were no treatment options available in conventional medicine.
As another important clinical outcome may be mentioned that 90% of patients who received VIDATOX ® 30 CH in the dose given, reported improvement of clinical symptoms based on consultation, and in 62% of them initial pain evolved into a mild form that did not require treatment necessarily to their relief, while 27% said absence of pain.
This latter aspect of his enormous influence on the quality of life of patients, is important to detail that 62% of patients with presence of severe pain with continuing need for medication (level 2), after treatment passed to the condition of minimal or moderate pain without medication (level 1).
Generally in patients comprising the sample are referred to herein has been:
- Improvement in pain
- Improvement of inflammation
- Improvement in hematologic parameters
- Improvement of appetite
- Improvement of general health
- Improved function in organs and systems affected
- Weight gain
- Reduction of cough
- Desire to live
We conclude that the use of 30 CH VIDATOX ®, can improve the quality of life, increase survival and slow tumor growth without the appearance of patients today cause undesirable symptoms and cytostatics radiation to which we subject our patients.
In this context, one should not ignore the massive consumption of the product for more of 26,000 people, from October 1 to April 10 of 2010 without reported adverse effects to date of application, confirming the preclinical experimental results.
MSC: Fabio De J. Linares Pazoz Production manager Laboratories Homeopathic Products LABIOFAM-CUBA
